Literature DB >> 10562705

Immune (dys)regulation in multiple sclerosis: role of the CD95-CD95 ligand system.

F Zipp1, P H Krammer, M Weller.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562705     DOI: 10.1016/s0167-5699(99)01545-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  13 in total

1.  Induction of autoreactive CD8+ cytotoxic T cells during Theiler's murine encephalomyelitis virus infection: implications for autoimmunity.

Authors:  Ikuo Tsunoda; Li-Qing Kuang; Robert S Fujinami
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Axon reactions precede demyelination in experimental models of multiple sclerosis.

Authors:  E Zapryanova; O S Sotnikov; S S Sergeeva; D Deleva; A Filchev; B Sultanov
Journal:  Neurosci Behav Physiol       Date:  2004-05

3.  Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects.

Authors:  E M Martínez-Cáceres; M A Barrau; L Brieva; C Espejo; N Barberà; X Montalban
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

4.  Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.

Authors:  M Ruggieri; C Avolio; S Scacco; C Pica; A Lia; G B Zimatore; S Papa; P Livrea; M Trojano
Journal:  J Neurol       Date:  2005-09-30       Impact factor: 4.849

Review 5.  [Multiple sclerosis: potential therapeutic options and update of ongoing studies].

Authors:  H Wiendl; H C Lehmann; R Hohlfeld; H-P Hartung; B C Kieseier
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

Review 6.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

7.  Thrombin-induced regulation of CD95(Fas) expression in the N9 microglial cell line: evidence for involvement of proteinase-activated receptor(1) and extracellular signal-regulated kinase 1/2.

Authors:  Jonathan R Weinstein; Matthew Zhang; Mansur Kutlubaev; Richard Lee; Caroline Bishop; Henrik Andersen; Uwe-Karsten Hanisch; Thomas Möller
Journal:  Neurochem Res       Date:  2008-08-07       Impact factor: 3.996

8.  Cross-sectional and longitudinal analysis of myelin-reactive T cells in patients with multiple sclerosis.

Authors:  Jan D Lünemann; Sandra Rückert; Florian Kern; Uwe Wendling; Ruud van der Zee; Hans D Volk; Frauke Zipp
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 9.  [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].

Authors:  C Kleinschnitz; S G Meuth; B C Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2007-08       Impact factor: 1.214

Review 10.  Oral disease-modifying treatments for multiple sclerosis: the story so far.

Authors:  Bernd C Kieseier; Heinz Wiendl
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.